This page is historical material reflecting the Feedback Loop Blog as it existed on March 25, 2020. This page is no longer updated and links to external websites and some internal pages may not work.
March 25, 2020

Archived: Urgent Competitive Revisions to NIGMS Grants to Address the Coronavirus Pandemic

By Judith Greenberg

We’ve published a notice of special interest (NOSI) (NOT-GM-20-025) to address the urgent need for research on the SARS-CoV-2 virus. We’ll accept competitive revisions (supplements) in three specific scientific areas:

  • Incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive models for the spread of SARS-CoV-2 and other related infectious agents (all grant and cooperative agreement activity codes)
  • Repurposing or modification of diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection (SBIR/STTR grants only)
  • Rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR grants only)

Please note that applications that aren’t responsive to these three areas will be withdrawn without review.

Applications will be accepted on a rolling basis until February 5, 2021, and will be evaluated quickly by an internal review panel convened by NIGMS staff. In addition to other review criteria, applications will be judged on the urgency, significance, and feasibility of the proposed research.

Awards will be made for 1 year. Competitive revisions to R15, R21, and R00 grants may provide support above the established budget limits for the parent awards.

Investigators interested in applying for competitive revisions in response to this NOSI are strongly encouraged to contact NIGMS staff. For inquiries related to predictive models, contact Daniel Janes. For inquiries related to SBIR/STTR, contact Dmitriy Krepkiy.

topic Funding Opportunities , Resources
tag Administrative Supplements , COVID-19

About the Author

Judith Greenberg

Judith Greenberg

Before her retirement in October 2020, Judith was the deputy director of NIGMS and the acting director of the Division of Biophysics, Biomedical Technology, and Computational Biosciences. In the past, she also served as the acting director of the Institute and as the director of the former Division of Genetics and Developmental Biology. She led the development of the NIGMS strategic plan issued in 2008 and the development and implementation of the NIGMS strategic plan for training issued in 2011.